Caliway Biopharmaceuticals (6919.TW) Q3 2025 Earnings

8AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.36
-0.94
-0.52
-0.1

Details

Expected EPS
-0.1363130875491
Actual EPS
-0.163985669232
Surprise EPS
-0.03
Surprise Percent
+20.3%

Description

Caliway Biopharmaceuticals (6919.TW) has reported earnings of -0.163985669232 per share for Q3 2025.

0 Comments

Share your thoughts